Zavicefta 2g/0.5g powder for concentrate for solution for infusion

  • Name:

    Zavicefta 2g/0.5g powder for concentrate for solution for infusion

  • Company:
    info
  • Active Ingredients:

    Ceftazidime Pentahydrate, Avibactam sodium

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 06/12/19

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 12/4/2019
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.

Click on this link to Download PDF directly

Pfizer Healthcare Ireland

Pfizer Healthcare Ireland

Company Products

Medicine NameActive Ingredients
Medicine Name Relpax 40mg Film-Coated Tablets Active Ingredients Eletriptan hydrobromide
Medicine Name Retacrit solution for injection in pre filled syringe Active Ingredients Epoetin Zeta
Medicine Name Revatio 0.8 mg/ml solution for injection Active Ingredients sildenafil citrate
Medicine Name Revatio 10 mg/ml powder for oral suspension Active Ingredients sildenafil citrate
Medicine Name Revatio 20 mg film-coated tablets Active Ingredients sildenafil citrate
Medicine Name Salazopyrin EN Tablets Active Ingredients Sulfasalazine
Medicine Name Salazopyrin Tablets Active Ingredients Sulfasalazine
Medicine Name Sildenafil Pfizer 25mg, 50mg, 100mg film–coated tablets Active Ingredients sildenafil citrate
Medicine Name Solu-Cortef Powder for Solution for Injection or Infusion 100 mg Active Ingredients Hydrocortisone sodium succinate
Medicine Name Solu-Medrone 1000mg Active Ingredients Methylprednisolone sodium succinate
Medicine Name Solu-Medrone 125 mg Active Ingredients Methylprednisolone sodium succinate
Medicine Name Solu-Medrone 40mg Active Ingredients Methylprednisolone sodium succinate
Medicine Name Solu-Medrone 500 mg Active Ingredients Methylprednisolone sodium succinate
Medicine Name Somavert 10mg, 15mg, 20mg, 25mg and 30mg Powder and Solvent for Solution for Injection Active Ingredients Pegvisomant
Medicine Name SUTENT 12.5mg, 25mg, 37.5mg and 50mg Hard Capsules Active Ingredients Sunitinib malate
Medicine Name Synarel Nasal Spray Active Ingredients nafarelin acetate
Medicine Name TicoVac 0.5 ml Suspension for injection in a prefilled syringe Active Ingredients Tick borne encephalitis vaccine
Medicine Name TicoVac Junior 0.25 ml Suspension for injection in a pre-filled syringe Active Ingredients Tick borne encephalitis vaccine
Medicine Name Tobramycin 40 mg/ml Solution for Injection Active Ingredients Tobramycin
Medicine Name TORISEL 30 mg concentrate and diluent for solution for infusion Active Ingredients Temsirolimus
Medicine Name Toviaz Prolonged-Release Tablets 4mg & 8mg Active Ingredients Fesoterodine Fumarate
Medicine Name Trazimera - 150mg & 420mg powder for solution for infusion Active Ingredients Trastuzumab
Medicine Name Trosyl 283mg/ml Nail Solution Active Ingredients Tioconazole
Medicine Name TRUMENBA Active Ingredients Meningococcal group B vaccine (recombinant, adsorbed)
Medicine Name Tygacil 50mg powder for solution for infusion Active Ingredients Tigecycline
176 - 200 of 227 items.Total: 10 pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 6 December 2019 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 15 April 2019 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 12 April 2019 SmPC

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 31 October 2018 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 31 October 2018 SmPC

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The SPC has been updated as follows:

Section 10: DATE OF REVISION OF THE TEXT has been updated – (10/2018)

Updated on 25 July 2018 PIL

Reasons for updating

  • Change to section 2 - excipient warnings
  • Improved presentation of PIL

Updated on 25 July 2018 SmPC

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Sections 4.2 (Posology and method of administration) and 4.8 (Undesirable effects) updated following completion of the paediatric study C3591004.

Section 4.4 sodium statement updated to align with the Annex to the EU Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’.

Updated on 6 February 2018 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 6 February 2018 SmPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The SPC has been updated as follows:
Section 7 - MA Holder address "Operations Services Group" corrected to "Operations Support Group".

Updated on 5 February 2018 PIL

Reasons for updating

  • New PIL for new product

Updated on 5 February 2018 PIL

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 8 January 2018 PIL

Reasons for updating

  • New PIL for new product

Updated on 8 January 2018 SmPC

Reasons for updating

  • New SPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

None provided